Pharmacologic studies of the antitumor agent 5-(dimethyltriazeno)imidazole-4-carboxamide.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000097:blood / Q000134:cerebrospinal fluid / Q000494:pharmacology* / Q000652:urine; D001806:Blood Urea Nitrogen; D001835:Body Weight; D055598:Chemical Phenomena; D002621:Chemistry; D002845:Chromatography; D003124:Colorimetry; D004285:Dogs; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000097:blood / Q000134:cerebrospinal fluid / Q000494:pharmacology* / Q000652:urine; D007275:Injections, Intravenous; D009369:Neoplasms / Q000188:drug therapy; D011485:Protein Binding; D013997:Time Factors
D000970:Antineoplastic Agents; D007093:Imidazoles